Stock Price Quote

ALEMBIC LTD.

NSE : ALEMBICLTDBSE : 506235ISIN CODE : INE426A01027Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE100.98-1.7 (-1.66 %)
PREV CLOSE ( ) 102.68
OPEN PRICE ( ) 102.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15318
TODAY'S LOW / HIGH ( )100.48 102.70
52 WK LOW / HIGH ( )85.55 153.45
NSE100.85-1.89 (-1.84 %)
PREV CLOSE( ) 102.74
OPEN PRICE ( ) 102.80
BID PRICE (QTY) 100.85 (15283)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 248072
TODAY'S LOW / HIGH( ) 100.25 102.81
52 WK LOW / HIGH ( )85.46 153.39
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-07 1907
Management Info
Chirayu Amin - Chairman Malika C Amin - Managing Director
Registered Office

Address Alembic Road,,,
Vadodara,
Gujarat-390003

Phone 0265-6637000

Email alembic.investors@alembic.co.in

Website www.alembiclimited.com

Registrars Details
MUFG Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
Listing : BSE, NSE

NEWS

20Sep Alembic informs about newspaper advert
Alembic has informed that it enclosed paper cuttings of newspaper advert..
05Jul Alembic informs about newspaper public
Alembic has informed that it enclosed a copy of the notice published in..
04Jul Alembic submits BRSR
Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations and Dis..
16May Alembic informs about press release
Alembic has informed that it enclosed a copy of Notice with respect to t..
25Feb Alembic informs about completion of t
Alembic has informed that Sameer Khera (DIN: 00009317) has completed his..

Financials

in Millions
QTR Sep 25 ANNUAL 25
Net Profit756.31419.5
Gross Profit 842 1519.9
Operating Profit 873.21640.6
Net Sales 540.42143.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  5689.30 (1.38%)
M.Cap ( in Cr)68024.12
Abbott India (BSE)
peergroup  28869.35 (0.15%)
M.Cap ( in Cr)61345.35
Glaxosmithkline Phar (BSE)
peergroup  2543.10 (1.35%)
M.Cap ( in Cr)43081.65
Wockhardt (BSE)
peergroup  1360.10 (2.16%)
M.Cap ( in Cr)22100.56
RPG Life Sciences (BSE)
peergroup  2228.80 (1.27%)
M.Cap ( in Cr)3686.22

Shareholding Pattern

PROMOTERS 70.88%
NON-INSTITUTION 27.7%
FI/BANKS/INSURANCE 0.04%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Alembic Ltd.

Alembic Ltd. was incorporated in the year 1907. Its today's share price is 100.98. Its current market capitalisation stands at Rs 2592.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2143.58 Cr and Total Income of Rs.2888.68 Cr. The company's management includes Keval Thakkar, Udit Amin, Jain Parkash, Girish Hirode, Sanjeev Shah, Mayurdhvaj Jadeja, Rati Desai, Malika C Amin, Chirayu Amin.

It is listed on the BSE with a BSE Code of 506235 , NSE with an NSE Symbol of ALEMBICLTD and ISIN of INE426A01027. It's Registered office is at Alembic Road,,Vadodara-390003, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are CNK & Associates LLP, K S Aiyer & Co., KS Aiyar & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.